Zymeworks (ZYME) Tops Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NYSE: ZYME) reported Q4 EPS of ($0.95), $0.22 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $19.87 million versus the consensus estimate of $9.13 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
